US Stock MarketDetailed Quotes

HSIC Henry Schein

Watchlist

70.970
+0.960+1.37%

Trading Dec 26 15:24 ET

8.85BMarket Cap29.09P/E (TTM)

Henry Schein Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Henry Schein Q3 2024 Earnings Date

Currency：USDNov 5, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	3.24B	3.17B	-61.58M
Miss Est.	+2.33%	+0.38%	-1.90%
EPS	0.89	0.78	-0.11
Miss Est.	-15.48%	-25.71%	-12.11%

Analyst Rating

Hold

Dec 26, 2024

Henry Schein Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 3.302B	--
--	2024/Q4	-- / 3.353B	--
Nov 5, 2024	2024/Q3	3.174B / 3.236B	--
Aug 6, 2024	2024/Q2	3.136B / 3.268B	--
May 7, 2024	2024/Q1	3.172B / 3.205B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 3.302B--

--2024/Q4-- / 3.353B--

Nov 5, 20242024/Q33.174B / 3.236B--

Aug 6, 20242024/Q23.136B / 3.268B--

May 7, 20242024/Q13.172B / 3.205B--

Unlock Free Earnings Estimates

Open Account

Henry Schein Earnings Reports

Henry Schein | 10-Q: Q3 2024 Earnings Report

Nov 5 14:51 ET

Henry Schein | 10-Q: Q2 2024 Earnings Report

Aug 6 14:03 ET

Henry Schein | 10-Q: Q1 2024 Earnings Report

May 7 16:01 ET

Henry Schein | 10-K: FY2023 Annual Report

Feb 28 14:18 ET

Trending US Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

COLL

+1.14%

Halozyme Therapeutics

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 26, 2024

Hold

Buy
40.00%
Hold
30.00%
Sell
30.00%

Price Target

No Data